This application is for a five year renewal of an institutional training grant titled """"""""Research Training in Neuro- Oncology"""""""" which has been funded by the NIH from 1987 to 2007. This training program is designed to prepare neurosurgeons, neurologists, medical oncologists, pediatric oncologists, radiation oncologists, radiologists, and other physician-scientists for academic careers in neuro-oncology. Physicians who have comp eted at least one year of postdoctoral training toward board certification in their subspecialty and are committed to a career in academic neuro-oncology are candidates for this research fellowship. Each year, four new trainees will be provided with a unique two year program that consists of: 1) Laboratory and/or clinical research under the supervision of an experienced scientist at the Johns Hopkins Medical Institutions, 2) Close interaction with a mentor with peer-reviewed funding in cancer research, 3) A didactic curriculum that includes biostatistics, epidemiology, clinical and laboratory research methods, biomedical writing, neuroanatomy, responsible conduct of research, and an overview of cancer research, 4) Clinical rotations with distinguished clinician scientists, and 5) Participation in neuro-oncology and basic and clinical cancer research conferences at Johns Hopkins and the NIH. This training program benefits from a stable, cohesive, and productive faculty with an exemplary track record of training academic neuro-oncologists, a close liaison with multiple departments and disciplines within the Johns Hopkins Medical Institutions, a multi-disciplinary approach to training as exemplified by the diversity of the faculty, and active clinical and basic science research focused on neuro-oncology. This program is designed to provide well-rounded research training to trainees and to develop them as the next generation of investigators in neuro-oncology.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Chesler, David A; Berger, Mitchell S; Quinones-Hinojosa, Alfredo (2012) The potential origin of glioblastoma initiating cells. Front Biosci (Schol Ed) 4:190-205
Yovino, Susannah; Grossman, Stuart A (2012) Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas. CNS Oncol 1:149-54
Bettegowda, Chetan; Agrawal, Nishant; Jiao, Yuchen et al. (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333:1453-5
Agrawal, Nishant; Frederick, Mitchell J; Pickering, Curtis R et al. (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333:1154-7
Chesler, D A; Pendleton, C; Jallo, G I et al. (2011) ""Colossal"" breakthrough: the callosal puncture as a precursor to third ventriculostomy. Minim Invasive Neurosurg 54:243-6
Hsu, Wesley; Dorsi, Michael J; Witham, Timothy F (2009) Surgical Management of Cervical Spondylotic Myelopathy. Neurosurg Q 19:302-307
Pradilla, Gustavo; Wang, Paul P; Gabikian, Patrik et al. (2006) Local intracerebral administration of Paclitaxel with the paclimer delivery system: toxicity study in a canine model. J Neurooncol 76:131-8
Stearns, Duncan; Chaudhry, Aneeka; Abel, Ty W et al. (2006) c-myc overexpression causes anaplasia in medulloblastoma. Cancer Res 66:673-81
Sampath, Prakash; Amundson, Eric; Wall, Monroe E et al. (2003) Camptothecin analogs in malignant gliomas: comparative analysis and characterization. J Neurosurg 98:570-7
Storm, Phillip B; Moriarity, John L; Tyler, Betty et al. (2002) Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy. J Neurooncol 56:209-17

Showing the most recent 10 out of 38 publications